Skip to content

Clinical trials

Phase 2 Fuchs' Endothelial Dystrophy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fuchs' Endothelial Dystrophy Phase: Phase 2 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20191
20203
20211
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aerie Pharmaceuticals1
Centre Hospitalier Universitaire de Saint Etienne1
Design Therapeutics, Inc.1
Emmecell1
Kowa Research Institute, Inc.1
Massachusetts Eye and Ear Infirmary1
Michael D. Straiko, MD1
Santen Inc.1
Trefoil Therapeutics, Inc.1
University of Erlangen-Nürnberg Medical School1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fuchs' Endothelial Dystrophy10
Corneal Edema2
Corneal Endothelial Cell Loss2
Keratoconus1

Trials

Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.